Apollo Proton Cancer Centre (APCC) has inaugurated its groundbreaking Centre of Excellence (CoE) for Head and Neck Cancer. With a comprehensive approach to cancer management and cutting-edge technologies, APCC is set to revolutionize the way head and neck cancer is treated, offering patients the best possible oncological outcomes while preserving their functionality and cosmesis.
Head and Neck cancer is a significant public health concern, with 57.5% of cases worldwide occurring in Asia. India bears a heavy burden, accounting for 30% of all head and neck cancers globally. In 2018, India recorded 1,19,992 new cases and 72,616 deaths due to oral cancers, earning the country the unfortunate title of being the “capital of oral cancers.” This alarming trend is often attributed to unique habits, such as tobacco chewing, and the high incidence of oral cancer associated with smokeless tobacco use.
Dr. Sapna Nangia, Director – Breast, Head & Neck, Department of Radiation Oncology, APCC, emphasized the gravity of the situation, saying, “The prevalence of head and neck cancer in India is a cause for concern, and it necessitates a specialized and integrated approach to treatment. APCC’s Centre of Excellence for Head and Neck Cancer is committed to providing the best possible oncological outcomes while prioritizing functional and cosmetic outcomes for our patients.”